GlaxoSmithKline (GSK) extended its their licensing agreement with GeneGo and added additional capability. The deal will provide GSK researchers in bioinformatics, R&D, and clinical studies with global access to GeneGo’s MetaCore, MapEditor, and MetaBase platforms.
